Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
1,150
1,100
1,049
1,003
931
818
Croissance des revenus (H/H)
-16%
5%
5%
8%
14%
5%
Coût des ventes
506
498
472
446
412
374
Bénéfice brut
643
602
577
557
518
443
Vente, Général et Administration
257
242
236
245
198
178
Recherche et développement
--
--
--
--
--
--
Frais d'exploitation
300
304
300
308
261
237
Autres revenus (charges) non opérationnels
7
5
7
6
15
9
Bénéfice avant impôts
121
113
106
-243
175
-38
Charge d'impôt sur le revenu
66
69
54
-9
58
-1
Bénéfice net
55
44
51
-233
115
-38
Croissance du bénéfice net
-28%
-14%
-122%
-303%
-403%
90%
Actions en circulation (diluées)
286.74
284.9
283.22
280.1
279.4
286
Variation des actions (H-H)
0%
1%
1%
0%
-2%
3%
EPS (dilué)
0.19
0.15
0.18
-0.83
0.41
-0.14
Croissance du EPS
-28.99%
-14%
-122%
-302%
-393%
75%
Flux de trésorerie libre
86
45
-362
95
179
67
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
55.91%
54.72%
55%
55.53%
55.63%
54.15%
Marge opérationnelle
29.82%
27%
26.31%
24.72%
27.49%
25.18%
Marge bénéficiaire
4.78%
4%
4.86%
-23.23%
12.35%
-4.64%
Marge du flux de trésorerie libre
7.47%
4.09%
-34.5%
9.47%
19.22%
8.19%
EBITDA
487
460
433
393
406
349
Marge EBITDA
42.34%
41.81%
41.27%
39.18%
43.6%
42.66%
D&A pour le résultat opérationnel
144
163
157
145
150
143
EBIT
343
297
276
248
256
206
Marge EBIT
29.82%
27%
26.31%
24.72%
27.49%
25.18%
Taux d'imposition effectif
54.54%
61.06%
50.94%
3.7%
33.14%
2.63%
Statistiques clés
Clôture préc.
$16.97
Prix d'ouverture
$16.99
Plage de la journée
$16.72 - $17.43
Plage de 52 semaines
$9.53 - $19.85
Volume
1.5M
Volume moyen
2.0M
BPA (TTM)
0.19
Rendement en dividend
--
Capitalisation boursière
$4.8B
Qu’est-ce que SHC ?
Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.